Royal Bank of Canada
MBVX

Royal Bank of Canada’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Royal Bank of Canada’s Portfolio MBVX Stock Details MBVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,999
Closed -$3K – 7225
2018
Q2 		$3K Hold
2,999
– – ﹤0.01% 6219
2018
Q1 		$5K Buy
+2,999
New +$6.48K ﹤0.01% 5964

Other funds holding MBVX

PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Royal Bank of Canada's MBVX Position: Q3 2018 in Review

Royal Bank of Canada sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q3 2018, closing a stake of 2,999 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in MBVX in Q1 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2018. 2 funds tracked by Wall St. Rank hold MBVX as of Q3 2018.

  • Royal Bank of Canada reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q3 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 2,999 MABVAX THERAPEUTICS HLDGS INC shares in Q3 2018, an estimated $3K.
  • Royal Bank of Canada first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q1 2018 and held it in 2 quarters.
  • Royal Bank of Canada's MABVAX THERAPEUTICS HLDGS INC position peaked at $5K in Q1 2018.
  • 2 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q3 2018.

Based on Royal Bank of Canada's 13F filing for Q3 2018, filed 14 Nov 2018.